Bozic Carmen sold VRTX
March 13, 2026 · Form 4 insider transaction
Bozic Carmen sold 2,329 shares of Vertex Pharmaceuticals Incorporated at $481.79 per share, a transaction worth $1.12M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,329
Price
$481.79
Total value
$1.12M
InsiderBozic Carmen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 13, 2026
Filing dateMarch 17, 2026
Shares owned after35,405
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.